Pennant Group Q2 revenue beats estimates on home health and hospice growth
PNTG•Updated 2026 outlook
Pennant Group raised its 2026 revenue guidance to $1.171 billion-$1.190 billion.
The company sees 2026 adjusted EPS at $1.34-$1.41 and expects adjusted EBITDA of $94.4 million-$98.0 million.
Quarterly results beat estimates
Pennant Group reported second-quarter revenue that rose 36% year-over-year, beating analyst expectations.
Adjusted earnings per share for the quarter also beat analyst expectations.
Key reported figures and analyst view
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Beat | $298 million | $288.71 million (7 analysts) |
| Q2 Adjusted EPS | Beat | $0.36 | $0.33 (7 analysts) |
| Q2 EPS | $0.25 | ||
| Q2 Net Income | $9.08 million |
The current average analyst rating on the shares is strong buy, with 7 strong buy or buy recommendations, no hold and no sell or strong sell ratings.
The average consensus recommendation for the healthcare facilities and services peer group is .
Related News
RMR Group FY26 Q3 net income falls 20.5% to $7.39 million; revenue dips 0.8% to $153.51 million
RMR•
Seaport Entertainment Group posts investor deck on experience-driven entertainment and hospitality platform, Seaport and Las Vegas assets
SEG•
